Please find the enclosed intimation of the Company as per the captioned subject for your reference.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India Ltd has received shareholder approval for shifting its Registered Office from the State of Karnataka to the State of Maharashtra. The approval was granted through a special resolution passed via Postal Ballot using remote e-voting, with results declared on May 11, 2026. The relocation will require amendment to the 2nd Clause of the company's Memorandum of Association and is subject to receiving necessary regulatory approvals under the Companies Act, 2013 and related rules. The company has submitted this intimation to BSE and NSE under SEBI's Regulation 30.
This is an administrative relocation that may offer operational or regulatory advantages given Maharashtra's status as a major commercial hub. No immediate financial impact is expected on shareholders, though the change could bring long-term strategic benefits.